Compare Vipshop Holdings Ltd - ADR (VIPS) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vipshop Holdings Ltd - ADR vs Zoetis Inc — how do they compare? Vipshop Holdings Ltd - ADR trades at $12.8 (market cap $5.95B), while Zoetis Inc trades at $73.65 (market cap $30.29B). The key difference: Zoetis Inc is far larger — about 5.1× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.96%). Which is the better fit depends on your goals.
| VIPS | ZTS | |
|---|---|---|
Market Cap | $5.95B | $30.29B |
Sector | Consumer Cyclical | Health |
52-Week High | $20.68 | $150.61 |
52-Week Low | $12.51 | $71.91 |
Enterprise Value | $2.78B | $37.86B |
Dividend Yield | 4.96% | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Vipshop Holdings trades at $13.03, down 1.29% on the day, with bearish technical signals dominating despite attractive valuation metrics. The company reported mixed Q2 2026 results with significant earnings misses, though maintains strong profitability with 9.82% net margin and 24.44% ROE. Recent institutional activity includes Nykredit A/S establishing a $2.35 million position in Q2 2026.
The stock presents a value opportunity with P/E of 4.21 and P/S of 0.41, but faces headwinds from declining revenue and challenging consumer sentiment. Analyst consensus leans bullish with 53.57% buy ratings, though technical indicators suggest near-term pressure. Key risks include Chinese consumer spending weakness and competitive pressures in e-commerce.
Zoetis (ZTS) trades at $73.6, down 2.92% on the day, near its 52-week low amid bearish technical signals. The stock shows strong fundamentals with a P/E of 12, net margin of 27.69%, and consistent earnings beats, but faces headwinds from weak U.S. companion animal sales and reduced 2026 guidance. Recent news includes an FDA emergency use authorization for Simparica Trio and participation in healthcare conferences.
The outlook is mixed: valuation appears attractive with a consensus price target of $93.40, but near-term risks include competitive pressures and soft pet health demand. Long-term investors may find value in its profitability and market dominance, though volatility persists from sector challenges and investor sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
